| 标题 |
TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study |
| 网址 | |
| DOI | |
| 其它 |
期刊:BMC Cancer 作者:Zhihong Tang; Tao Bai; Tao Wei; Xiaobo Wang; Jie Chen; et al 出版日期:2024-06-11 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)